Skip to content

Xometry, Inc. XMTR Convertible debentures

Convertible debentures at other companies

DexCom logo
DexComDXCM
$0
Dropbox logo
DropboxDBX
$690.3M+0.2%
Mirum Pharmaceuticals, Inc. logo
Mirum Pharmaceuticals, Inc.MIRM
$310.25M+0.6%
Nutanix, Inc. logo
Nutanix, Inc.NTNX
$1.35B+0.4%
Applied Optoelectronics logo
Applied OptoelectronicsAAOI
$129.52M-3.5%
Varonis Systems logo
Varonis SystemsVRNS
$452.77M-35.5%

Other financials

Income statement

See full
Revenue$205.1M+35.9%
Gross profit$78.5M+39.3%
Operating income-$5.2M+66.1%
Net income-$5.3M+65.1%
EPS (diluted)-$0.10+66.7%

Balance sheet

See full
Cash & equivalents$21.0M+35.7%
Total debt$97.0M+889%
Total equity$282.0M-9.0%
Total assets$740.3M+7.3%

Cash flow

See full
Operating cash flow$14.6M+496%
CapEx$10.3M+126%
Free cash flow-$5.9M

Valuation

See full
Market cap$5.07B+68.8%

Profitability

See full
Gross margin39.3%+0.2pp
Operating margin-4.8%-1.6pp
Net margin-7%-1.1pp
FCF margin-3.5%

Returns & leverage

See full
Return on equity-17.5%+2.7pp
Debt / equity0.3×+0.3×
Current ratio1.8×-2.0×

Where this comes from

Reported directly by Xometry, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ConvertibleDebtNoncurrent.

The official record: Xometry, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Xometry, Inc.'s convertible debentures.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Xometry, Inc.'s convertible debentures?
Xometry, Inc. (XMTR) reported convertible debentures of $242.74M in Q1 2026.
How has Xometry, Inc.'s convertible debentures changed year-over-year?
Xometry, Inc.'s convertible debentures decreased by 14.6% year-over-year, from $284.09M to $242.74M.
What is the long-term trend for Xometry, Inc.'s convertible debentures?
Over 3 years (2022 to 2025), Xometry, Inc.'s convertible debentures has grown at a 5.4% compound annual growth rate (CAGR), from $279.91M to $327.51M.